The new drink, called alcosynth, is designed to mimic the sociable side of alcohol, while not causing hangover symptoms, damages to the liver, or loss of control.
Soon, you might be able to hack the whole of freshers’ week without taking a night off as Imperial College Professor, David Nutt, has patented 90 different alcosynth compounds.
What is Alcosynth?
It’s a derivative of benxodiazepine – a common drug used to treat anxiety, but doesn’t cause withdrawal symptoms.
It is, however, part of the Valium family.
How will it be drank?
Professor Nutt told the Independent: “It will be there alongside the scotch and the gin, they’ll dispense the alcosynth into your cocktail and then you’ll have the pleasure without damaging your liver and your heart.”
Why is it not in bars yet?
According to Sky News, over-regulation is stopping such products entering the market.
Sam Bowman, executive director of the Adam Smith Institute says “It’s innovation not regulation that got us e-cigarettes. They emerged and prospered in spite of regulation, proving to be the best way to get people to quit quickly that we know of.”
He further went on to say “Regulation must be flexible and encouraging of new products that are safer than the vices they’re competing with.”
The Telegraph, however, reported that it could be ready to market in a years’ time.
This has been talked/planned about for years. Why can I not buy this product yet? I WANT MY ALCOSYNTH! pic.twitter.com/yMoIjiDYla
— Alex Marsh (@okAlexMarsh) October 5, 2015
Back in 2015, Nutt also announced a drug called “Chaperone” which, when taken with alcohol, sobers you up right away. But this hasn’t appeared on the market as of yet, so I’m not holding out for alcosynth coming anytime in the very near future.